Literature DB >> 25444792

On birth single dose live attenuated OPV and BCG vaccination induces gut cathelicidin LL37 responses at 6 week of age: a natural experiment.

Md Jahangir Alam1, Md Mamunur Rashid1, Yearul Kabir2, Rubhana Raqib1, Shaikh Meshbahuddin Ahmad3.   

Abstract

In a cross sectional study, we show that infants who received single dose of live attenuated OPV and BCG vaccines within 48h of birth, have higher excretion of human cathelicidin LL37 (p<0.05) in stool at 6wk of age. This response remained unchanged in multivariate analysis after adjusting for sex, mode of delivery, infant age, mother age birth weight and breast milk feeding pattern. This analysis also reveals that irrespective of vaccination, girl infants have higher human-beta-defencin2 (HBD2) and exclusively breastfed infants have higher total and anti-polio specific IgA to all three subtypes in stool (p<0.05). However, vaccination induces anti-polio IgA responses only to infants who are exclusively breastfed. Thus on-birth live attenuated vaccination may provide non-specific beneficial effect against infections while exclusive breastfeeding enhance protection by boosting vaccine induced IgA. The result also suggests that in polio endemic area, exclusive breastfeeding may be sufficient for mucosal anti-polio responses during early infancy.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMP; LL-37; Non-specific effect; OPV

Mesh:

Substances:

Year:  2014        PMID: 25444792     DOI: 10.1016/j.vaccine.2014.10.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Cord blood antimicrobial peptide LL37 levels in preterm neonates and association with preterm complications.

Authors:  Zhuxiao Ren; Wenhui Mo; Liling Yang; Jianlan Wang; Qi Zhang; Zhicheng Zhong; Wei Wei; Zhipeng Liu; Zhiping Wu; Yao Yao; Jie Yang
Journal:  Ital J Pediatr       Date:  2022-07-08       Impact factor: 3.288

Review 2.  The potential for immunoglobulins and host defense peptides (HDPs) to reduce the use of antibiotics in animal production.

Authors:  Albert van Dijk; Chris J Hedegaard; Henk P Haagsman; Peter M H Heegaard
Journal:  Vet Res       Date:  2018-07-31       Impact factor: 3.683

3.  Cyclic Di-Adenosine Monophosphate: A Promising Adjuvant Candidate for the Development of Neonatal Vaccines.

Authors:  Darío Lirussi; Sebastian Felix Weissmann; Thomas Ebensen; Ursula Nitsche-Gloy; Heiko B G Franz; Carlos A Guzmán
Journal:  Pharmaceutics       Date:  2021-02-01       Impact factor: 6.321

4.  The Effect of Oral Polio Vaccine at Birth on Infant Mortality: A Randomized Trial.

Authors:  Najaaraq Lund; Andreas Andersen; Anna Sofie K Hansen; Frida S Jepsen; Amarildo Barbosa; Sofie Biering-Sørensen; Amabelia Rodrigues; Henrik Ravn; Peter Aaby; Christine Stabell Benn
Journal:  Clin Infect Dis       Date:  2015-07-28       Impact factor: 9.079

5.  Anti-microbial peptide gene expression during oral vaccination: analysis of a randomized controlled trial.

Authors:  M Simuyandi; M Kapulu; P Kelly
Journal:  Clin Exp Immunol       Date:  2016-08-29       Impact factor: 4.330

6.  National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials.

Authors:  Andreas Andersen; Ane Baerent Fisker; Amabelia Rodrigues; Cesario Martins; Henrik Ravn; Najaaraq Lund; Sofie Biering-Sørensen; Christine Stabell Benn; Peter Aaby
Journal:  Front Public Health       Date:  2018-02-02

7.  National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: Analysis of 2004-2019 demographic surveillance data in rural Bangladesh.

Authors:  Sebastian Nielsen; Md Abdul Khalek; Christine Stabell Benn; Peter Aaby; Syed Manzoor Ahmed Hanifi
Journal:  EClinicalMedicine       Date:  2021-05-24

8.  Functional Antibodies and Innate Immune Responses to WRSS1, a Live Oral Shigella sonnei Vaccine Candidate, in Bangladeshi Adults and Children.

Authors:  Protim Sarker; Akhirunnesa Mily; Anjuman Ara; Farjana Haque; Nicole Maier; Thomas F Wierzba; Richard I Walker; Malabi M Venkatesan; Rubhana Raqib
Journal:  J Infect Dis       Date:  2021-12-20       Impact factor: 5.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.